Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Viola Regondi"'
Autor:
Tiziana Triulzi, Luca Forte, Viola Regondi, Martina Di Modica, Cristina Ghirelli, Maria Luisa Carcangiu, Lucia Sfondrini, Andrea Balsari, Elda Tagliabue
Publikováno v:
OncoImmunology, Vol 8, Iss 1 (2019)
Through whole-transcriptome profiling of HER2+ breast carcinomas (BCs), we previously showed that those sensitive to trastuzumab are addicted to this oncoprotein and are enriched in immune pathways, raising the hypothesis that HER2 itself regulates i
Externí odkaz:
https://doaj.org/article/f7c38e515dcd42adba9b486f12cd05e3
Autor:
Elda Tagliabue, Tiziana Triulzi, Andrea Balsari, Simone Guglielmetti, Fabio Corsi, Laura Villani, Claudio Tripodo, Alessia Bertolotti, Francesca Bianchi, Elena Fasano, Loris De Cecco, Beatrice Belmonte, Stefania Arioli, Arianna Bonizzi, Viola Regondi, Giorgio Gargari, Martina Di Modica
Supplementary Table S2-S4. Pathway enrichment analysis by DAVID and GSEA in the ileum and colon of antibiotic treated mice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e9571e1f20b91fbb409ebae2baa5146
https://doi.org/10.1158/0008-5472.22430065
https://doi.org/10.1158/0008-5472.22430065
Autor:
Elda Tagliabue, Tiziana Triulzi, Andrea Balsari, Simone Guglielmetti, Fabio Corsi, Laura Villani, Claudio Tripodo, Alessia Bertolotti, Francesca Bianchi, Elena Fasano, Loris De Cecco, Beatrice Belmonte, Stefania Arioli, Arianna Bonizzi, Viola Regondi, Giorgio Gargari, Martina Di Modica
1. Supplementary Materials and Methods Table S1. List of the antibodies used for flow cytometry 2. Supplementary Figures Supplementary Fig. S1. Impact of antibiotic treatment on trastuzumab efficacy and the tumor microenvironment. Supplementary Fig.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf7df44e3cc112175e083203e7d405bd
https://doi.org/10.1158/0008-5472.22430068
https://doi.org/10.1158/0008-5472.22430068
Autor:
Elda Tagliabue, Tiziana Triulzi, Andrea Balsari, Simone Guglielmetti, Fabio Corsi, Laura Villani, Claudio Tripodo, Alessia Bertolotti, Francesca Bianchi, Elena Fasano, Loris De Cecco, Beatrice Belmonte, Stefania Arioli, Arianna Bonizzi, Viola Regondi, Giorgio Gargari, Martina Di Modica
Emerging evidence indicates that gut microbiota affect the response to anticancer therapies by modulating the host immune system. In this study, we investigated the impact of gut microbiota on immune-mediated trastuzumab antitumor efficacy in preclin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa07840f86325bba8cbd23b656d345d6
https://doi.org/10.1158/0008-5472.c.6513535.v1
https://doi.org/10.1158/0008-5472.c.6513535.v1
Autor:
Elda Tagliabue, Viola Regondi, Arianna Bonizzi, Tiziana Triulzi, Giorgio Gargari, Simone Guglielmetti, Stefania Arioli, Fabio Corsi, Martina Di Modica
Publikováno v:
Cancer Research. 80:P4-10
Although the clinical benefit of trastuzumab for the management of HER2-positive breast carcinomas (BCs) has been largely demonstrated, many women, even those reported to have tumors potentially most sensitive to trastuzumab (e.g., HER2-enriched by P
Autor:
Tiziana Triulzi, Viola Regondi, Elisabetta Venturelli, Patrizia Gasparini, Cristina Ghirelli, Jessica Groppelli, Martina Di Modica, Francesca Bianchi, Loris De Cecco, Lucia Sfondrini, Elda Tagliabue
Publikováno v:
Cancers; Volume 14; Issue 22; Pages: 5650
While the results thus far demonstrate the clinical benefit of trastuzumab in breast cancer (BC), some patients do not respond to this drug. HER2 mRNA, alone or combined with other genes/biomarkers, has been proven to be a powerful predictive marker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33aa3fbac8777f74b979f5e635f9af31
https://hdl.handle.net/2434/946447
https://hdl.handle.net/2434/946447
Autor:
Viola Regondi, Stefania Arioli, Elda Tagliabue, Arianna Bonizzi, Francesca Bianchi, Beatrice Belmonte, Alessia Bertolotti, Claudio Tripodo, Andrea Balsari, Elena Fasano, Tiziana Triulzi, Loris De Cecco, Fabio Corsi, Martina Di Modica, Simone Guglielmetti, Giorgio Gargari, Laura Villani
Publikováno v:
Cancer research. 81(8)
Emerging evidence indicates that gut microbiota affect the response to anticancer therapies by modulating the host immune system. In this study, we investigated the impact of gut microbiota on immune-mediated trastuzumab antitumor efficacy in preclin
Publikováno v:
Cancer Research. 77:P4-21
It is well know that trastuzumab activity against HER2-positive breast carcinomas (BCs) depends also on immune cells. Our genomic analysis of 53 HER2-positive BCs indicated that those exquisitely sensitive to treatment are addicted to this oncoprotei
Autor:
Sarah E. Holton, Elda Tagliabue, Biagio Paolini, Viola Regondi, Rohit Bhargava, Saumya Tiwari, Tiziana Triulzi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Molecular analysis techniques such as gene expression analysis and proteomics have contributed greatly to our understanding of cancer heterogeneity. In prior studies, gene expression analysis was shown to stratify patient outcome on the basis of tumo
Autor:
Maria Rosa Cappelletti, Elda Tagliabue, Loris De Cecco, Martina Di Modica, Tiziana Triulzi, Daniele Generali, Serena Di Cosimo, Biagio Paolini, Pier Luigi Lollini, Viola Regondi, Lucia Sfondrini
Publikováno v:
British Journal of Cancer
Background: Optimising the selection of HER2-targeted regimens by identifying subsets of HER2-positive breast cancer (BC) patients who need more or less therapy remains challenging. We analysed BC samples before and after treatment with 1 cycle of tr